American journal of respiratory and critical care medicine
A Step toward an Optimized Rifampin Dose Completed.
Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
On Treatment Outcomes of Patients with HIV and Tuberculosis.
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.
Update in tuberculosis and nontuberculous mycobacterial disease 2011.
Update in tuberculosis and nontuberculous mycobacterial disease 2012.
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.
Modern age pathology of pulmonary arterial hypertension.
Fat and cardiotoxicity in hereditary pulmonary hypertension.
